HomeStocksMANGALAM

M

Mangalam Drugs & Organics

MANGALAM Share Price

Healthcare

80.68

-1.48 (-1.80%)loss

as on 13 Jun 2025 at 15:29

1D
Bulb

Today Mangalam Drugs & Organics opened at 79.51 while its previous close was at 82.16. In todays trading session MANGALAM reached a high of 82.81 and low of 79.51. The average traded price for today is 81.18. The 50 DMA stands at 79.34 and 200 DMA is at 102.98. Looking at intraday trend, the stock is in Downtrend.

chartsarrowTradingViewarrow
TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

MANGALAM Stock Performance

Markets Today

High

82.81

Low

79.51

Open at

79.51

Prev Close

82.16

Volumes

21,983

Avg Price

81.18

Lower Circuit

64.54

Upper Circuit

96.81

Last Traded Details

Quantity

50

Time

15:29:08

Price Movement

79.51
80.68
82.81
Loss 1.47%down side
up side2.57% profit

Historical Performance

3 M High

86.01

3 M Low

70.10

1 Yr High

144.99

1 Yr Low

70.10

3 Yr High

173.00

3 Yr Low

70.10

5 Yr High

196.95

5 Yr Low

60.75

1-Year Performance

70.10
80.68
144.99
loss1.47%down side
up side2.57% profit

MANGALAM Latest News

View All News arrow
news

No news for this stock at the moment.


MANGALAM Share Price History

View Price History arrow
No data

Sorry, No Data Available at this Moment!


MANGALAM Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

128

PE Ratio

19.40

PB Ratio

0.87

Dividend Yield

-

ROE

-6.68%

ROCE

1.68%

Book Value (₹)

94.12

Face Value (₹)

10.00


Share Holding Pattern

Held ByMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Promoters
50.32%50.32%50.30%50.30%50.30%
Domestic Institutional Investors (DII)
0.00%0.00%0.00%0.00%0.00%
Foreign Institutional Investors (FII)
0.26%0.21%0.11%0.11%0.47%
Public Investors
44.22%44.70%44.91%44.78%44.55%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


MANGALAM Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


MANGALAM Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA82.24Bearish
10-SMA81.88Bearish
20-SMA81.06Bearish
50-SMA79.34Bullish
100-SMA87.46Bearish
200-SMA102.98Bearish

Technical Indicators

IndicatorValueAction
RSI(14)49.65Neutral
ATR(14)3.13Volatile
STOCH(9,6)55.44Neutral
STOCH RSI(14)49.70Neutral
MACD(12,26)0.05Bullish
ADX(14)18.03Weak Trend

Summary of Technical Indicators for MANGALAM


MANGALAM Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
10277808973

MANGALAM Financials

View By:

Income Statement

In Crores

Quarterly StatementMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Revenue10277808973
Expenses9168718063
Operating Profit1189910
Operating Profit Margin %11%11%11%10%14%
Other Income00000
EBITDA1289910
Interest44444
Depreciation44445
Profit Before Tax41112
Tax %10%-362%-124%6%96%
Net Profit43310
EPS22210

Balance Sheet

In Crores

Yearly Balance SheetMar 2024
Share Capital16
Reserve & Surplus120
Minority Interest0
Non Current Liabilities34
Current Liabilities164
Total Liabilities334
Fixed Assets148
Capital Work in Progress8
Investments0
Other Assets178
Total Assets334

Cash Flow

In Crores

Yearly Cash FlowMar 2024
Operating Activities4
Investing Activities-12
Financing Activities5
Net Cash Flow-3

Past Corporate Actions

DateCorporate ActionInformation
14 May 2025
Quarterly Result Announcement
NA
05 Feb 2025
Quarterly Result Announcement
NA
08 Nov 2024
Quarterly Result Announcement
NA
04 Sep 2024
Annual General Meeting
NA

ScanX Logo

Get In-depth View of MANGALAM Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

MANGALAM Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-24369
-0.98% Loss
-9
-812.51% Loss
FY 2022-23373
-17.47% Loss
1
-93.54% Loss
FY 2021-22451
18.71% profit
20
-29.72% Loss




Open IPOs

View All arrow
No Data

There are no Open IPOs at the moment.



What’s New In The Market
icon
C

City Union Bank: Targets Industry-Beating Growth by FY26

sentiment_img

City Union Bank aims to outpace industry growth by 200-300 basis points in FY26. CEO N Kamakodi projects 13-15% growth over the next five years. The bank is expanding geographically outside Tamil Nadu and expects investments in retail banking to contribute to profitability from 2026-27. It aims to reduce its cost-to-income ratio to around 45% within five years.

CUB

196.20

1.02
(0.52%) profit
11 hours ago

icon
I

IndiGo Airlines: Insurance Costs Set to Soar Amid Geopolitical Risks

sentiment_img

IndiGo, India's largest airline, faces potential surge in aviation insurance costs during policy renewal next month. Factors include increased geopolitical risks and reduced reinsurance capacity following the recent Air India crash. IndiGo's current fleet of 437 aircraft has a total insurance cover of $20 billion with an annual premium of $14-15 million.

INDIGO

5,262.00

-214.50
(-3.92%) profit
19 hours ago

icon
A

Adani Ports: Shares Fall Amid Iran-Israel Conflict Threats to Haifa Port

sentiment_img

Adani Ports and Special Economic Zone (APSEZ) shares dropped over 3% due to potential threats to Haifa Port from Iran-backed Houthi rebels amid escalating Israel-Iran tensions. The decline followed Israel's strikes on Iranian military and nuclear sites, raising fears of broader regional conflict.

ADANIPORTS

1,405.00

-40.80
(-2.82%) profit
1 days ago

FAQs

Mangalam Drugs & Organics share price as of today is ₹ 80.68 as on 13 Jun 2025 at 15:29.
The 52W high of Mangalam Drugs & Organics is ₹ 144.99 and 52W low is ₹ 70.10 as of 13 Jun 2025 at 15:29.
The past returns of Mangalam Drugs & Organics share are -
  • Past 1 year: -25.12%
  • Past 3 years: -46.80%
  • Past 5 years: 16.00%
The PE and PB ratio of Mangalam Drugs & Organics stands at 19.40 and 0.87 respectively as on 13 Jun 2025 at 15:29.
The EPS of Mangalam Drugs & Organics is 0.04 for the quarter ended Mar 2025 and -5.73 for the financial year 2023-24.
The shareholding pattern of Mangalam Drugs & Organics is as follows:
  • DIIs - 0.00%
  • FII - 0.47%
  • Promoters - 50.30%
  • Public Investors 44.55%
  • Goverenment - 0.00%
Yes, you can buy shares of Mangalam Drugs & Organics online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Mangalam Drugs & Organics stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Mangalam Drugs & Organics share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Mangalam Drugs & Organics.
You can easily buy the shares of Mangalam Drugs & Organics even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in MANGALAM
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors